LifeMD Announces Board and Executive Compensation Changes
Ticker: LFMDP · Form: 8-K · Filed: Oct 31, 2024 · CIK: 948320
Sentiment: neutral
Topics: board-changes, executive-compensation
Related Tickers: LFMD
TL;DR
LifeMD shakes up board, adjusts exec pay. New director in, old one out.
AI Summary
LifeMD, Inc. announced on October 25, 2024, a change in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, along with updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, potentially impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can sometimes precede or accompany significant strategic shifts or financial performance issues.
Key Players & Entities
- LifeMD, Inc. (company) — Registrant
- October 25, 2024 (date) — Date of earliest event reported
- October 30, 2024 (date) — Date as of change
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY 10001 (address) — Business and Mail Address
FAQ
Who departed from the LifeMD board of directors?
The filing indicates the departure of a director, but does not name the individual in the provided excerpt.
Who was elected to the LifeMD board of directors?
The filing states a new director was elected, but does not provide the name in the excerpt.
What is the primary purpose of this 8-K filing?
This 8-K filing reports on the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported is dated October 25, 2024.
What is LifeMD, Inc.'s business address?
LifeMD, Inc.'s business address is 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY 10001.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-10-30 19:00:09
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share LFMD The Nasdaq Capital M
- $0.0001 — A Cumulative Perpetual Preferred Stock, $0.0001 per share LFMDP The Nasdaq Capital
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-043097.txt ( ) — 254KB
- lfmd-20241025.xsd (EX-101.SCH) — 4KB
- lfmd-20241025_def.xml (EX-101.DEF) — 29KB
- lfmd-20241025_lab.xml (EX-101.LAB) — 36KB
- lfmd-20241025_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFEMD, INC. Dated: October 30, 2024 By: /s/ Eric H. Yecies Eric H. Yecies Chief Legal Officer and General Counsel